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The leukemias afford a unique opportunity to study the differentiation path-
ways of various hematopoietic lineages because neoplastic cells can be considered
clonal counterparts of normal cells frozen at various stages of maturation .
Monoclonal antibodies directed against a variety of differentiation-associated
antigens have provided the means to identify specific molecules that reflect
characteristic if not unique, phenotypic patterns in the various lymphoid and
nonlymphoid lineages (1-4) . More recently, therehas been considerable progress
in delineating certain early differentiation events in the lymphoid lineage through
an analysis of the clonal somatic rearrangements of immunoglobulin and T-cell
receptor genes, which provide irreversible markers of lineage, clonality, and
stage of differentiation (5-12) . However, insufficient information has been
accumulated about the critical early events of hematopoietic differentiation, i .e .,
the mechanisms that determine the commitment ofa cell to a particular lineage.
In this context, although neoplastic phenotypes are not always precise replicas
of normal ones, lineage specificity is, in general, faithfully conserved in leukemias
and lymphomas, as shown by conservation of lineage-specific cell surface markers
in both myeloid and lymphoid leukemias (4, 13) and by the presence of B or T
cell-specific gene rearrangements in lymphoid leukemias and lymphomas (5-
12) . However, a simple theory for lineage commitment stating the irreversible
entrance of cells into one of the differentiation lineages is questioned by findings
of apparently anomalous expression of myeloid or lymphoid markers outside of
their respective lineages (13) . These phenomena, which include the presence of
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GENE REARRANGEMENTS IN ACUTE MYELOGENOUS LEUKEMIAS
nuclear terminal deoxyribonucleotidyltransferase (TdT)' in leukemic myelo-
blasts (14-16), and the inappropriate rearrangement of an immunoglobulin (Ig)
or T cell receptor (TCR) gene in lymphoid or myeloid lineage cells (17-20),
have been collectively referred to as "lineage infidelity" (21) . This concept,
however, implies a somewhat anomalous or pathologic nature of these events,
while it remains entirely possible that they reflect normal stages of differentiation
that are frozen or selected by the leukemic transformation . Reflecting this
alternative explanation and the unresolved nature of the controversy, "lineage
infidelity" has been recently renamed "lineage promiscuity" to symbolize the
possible physiologic rather than pathologic nature of these events (13) .
A potentially informative approach to this problem is to determine whether
the unfaithful or promiscuous expression of a given marker represents the
isolated, sporadic activation of a single gene or is part of a more complex
differentiation program involving the coordinated expression of multiple genes
and their products . Of considerable interest in this respect are leukemia cases
that consistently display anomalous markers and in which the original lineage
derivation can be studied by analyzing Ig orT# gene rearrangements as irrever-
sible immunogenotypic footprints of previous "commitments ." Such an oppor-
tunity is afforded by the subgroup of acute myelogenous leukemias (AML)
accounting for approximately one-tenth of AMLs, which are characterized by
myelomonocytic cytochemistries and cell surface antigens ; by the concomitant
expression ofTdT, a lymphoid lineage-associatedmarker ; and bypoor prognosis
(14-16) . Because the nuclear enzyme TdT has been postulated to play a role in
the generation of Ig and T cell receptor diversity (22, 23), we investigated
whether, in myeloid leukemias, these two uncommon events, generearrangement
and TdT expression, might be associated and represent activation, albeit abortive
or transient, of a program of lymphoid initiation expressed before irreversible
commitment .
Our results demonstrate that TdT expression and Ig and Ts gene rearrange-
ment are strongly associated . Rearrangements were observed in >60% of the
TdT+ AMLs and in all of the TdT' undifferentiated leukemias we studied . The
implications of these findings for both normal and neoplastic cell differentiation
and for the relationship between TdT function and Ig and T# gene rearrange-
ment are discussed.
Materials and Methods
Specimens. Representative samples of peripheral blood were collected during the
course of standard diagnostic procedures . The diagnosis of each myeloid leukemia was
established by conventional (FAB) diagnostic criteria (24) . Specifically, Jenner-Giemsa,
Sudan black B (SBB), myeloperoxidase (MP), periodic acid-Schiff (PAS), acetyl-butyrate
esterase (ABE), and a-napthyl acetate esterase (ANAE) were performed, and the leukemias
classified as myeloid were scored as positive with SBB/MP and/or the esterases and were
scored as negative with PAS . The leukemias considered to be undifferentiated failed to
react with any of these reagents. A mononuclear cell suspension of >95% viability was
prepared from each specimen by Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway,
NJ) and where necessary, Percoll (Pharmacia Fine Chemicals) density gradient centrifuga-
' Abbreviations used in this paper:
￿
ABE, acetyl-butyrate esterase; AML, acute myelogenous leu-
kemia ; MP, myeloperoxidase; PAS, periodic acid-Schiff; SBB, Sudan black B ; TdT, terminal
deoxyribonucleotidyltransferase .SEREMETIS ET AL .
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tion . The vast majority, >85%, of the mononuclear cells isolated from each specimen
were cytomorphologically neoplastic .
Cell Marker Analysis.
￿
The presence of cell surface Ig (sIg), cytoplasmic heavy chains
(CA), sheep erythrocyte (E) rosette formation, HLA-DR antigens, and TdT were deter-
mined as previously described (14, 25) . The expression of myeloid and lymphoid differ-
entiation antigens was determined by indirect immunofluorescence and flow cytometry
using a panel ofmAB (OKT3 [CD3], OKT4 [CD4], OKT6 [CD I], OKT8 [CD8], OKT 11
[CD2], Leu-1 [CD5], B1 [CD20], B2 [CD21], B4 [CD19], BA-1 [CD24], BA-2 [CD-9],
anti-CALLA [CD10], Leu-9/3AI [CD7], Mo-1 [CD11], MoU26, MY9 [gp67],
MoU48/My7 [CD13], Leu-M3 [CD14]) the characteristics and reactivity of which have
been previously determined (1, 2, 3) . A cell population was considered positive if>25%
of the neoplastic cells reacted with the mAB .
DNA Extraction and Southern Blot Analysis .
￿
DNA was prepared by cell lysis, proteinase
K digestion, extraction with phenol, and precipitation with ethanol (26) . 15 tag of DNA
were digested with Eco RI or Bam HI restriction endonucleases, electrophoresed in a
0 .8% agarose gel, denatured, neutralized, transferred to a nitrocellulose filter, and
hybridized according to Southern (27) . Filters were washed in 0 .2X standard sodium
citrate, 0.5% SDS, pH 7, at 60° for 2 h (28) .
DNA Probes.
￿
The T# probe used in this study was derived from a human cDNA T#
clone (YTJ-2) isolated from the Jurkat-2 T lymphoma cell line (a gift from Dr . T . Mak,
Ontario Cancer Institute, Toronto, Canada) . This clone hybridizes to both alleles (COI
and C,62) of the constant (T, 3C) region, and to one or more alleles of the variable (V)
regions (10, 29) . To generate a probe representative for the TOC region, the insert of the
YTJ-2 plasmid was digested with Hinc II restriction endonuclease, and the 0.8 kilobase
(kb) To C-specific fragment was purified by preparative agarose gel electrophoresis . The
Hinc 11 restriction separated the V from the C regions by interrupting the joining (])
region (8) . The probe for the Ig locus, representative of the J region (JH ) of the heavy
chain (IgH) locus, was obtained from Dr . Stanley Korsmeyer (National Institutes of
Health, Bethesda, MD) and has already been described (5, 6) . DNA fragments were "P-
labelled by nick translation for use as probes (27).
Results
TdT- AML Display Infrequent T# and IgH Gene Rearrangements.
￿
We investi-
gated the occurrence of Ts and Ig rearrangements in a panel of 25 leukemias
defined as classical TdT-AML (FAB M1-M5) on the basis of morphology and
cytoenzymatic analysis . Cell surface antigens other than those characteristic of
myeloid differentiation were not detected in any of these leukemic samples . In
particular, the CD7 antigen was not expressed by any of these leukemias .
The genomic organization of the Tsand IgH loci were studied in these AMLs
by Southern blot hybridization using the T#C probe and JH probe respectively .
Based on previous observations, Eco RI and Bam HI digestion were used to
identify DNA rearrangements of the T, 9 locus (10), and Eco RI digestion was
used to identify the rearrangements of the IgH locus (6) . The results are
summarized in Table I . 23 of the 25 classical TdT- AMLs did not exhibit
rearrangement ofeither the Ts or the IgH locus . OneFAB-M2 leukemia displayed
rearrangement at theTs locus, and one FAB-M3 leukemia displayed rearrange-
ment at the IgH locus .
TdT Expression Identifies a Subset of AML with a High Frequency of Clonal
Rearrangements ofIgH or T# Loci. We investigated the occurrence of T, 3 and IgH
rearrangements in a panel of 13 acute leukemias defined as TdT+ AMLs . All 13
cases had in common the diagnostic features of AML, including positive cyto-
chemical staining for myeloperoxidase and the expression of myeloid lineage-1706
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TABLE I
A Summary ofImmunogenotypicAnalysis ofTdT- Myeloid Leukemias
TABLE II
TdT' Myeloid Leukemias: Diagnostic, Immunophenotypic, andImmunogenotypic Features
* T 1, T6, and T I I are negative in all cases .
In all CD7+ cases, double immunofluorescent staining demonstrated coexpression of CD 13 and
CD7 antigens .
¢ R, rearranged; G, germline .
Double immunofluorescent staining demonstrated coexpression of CD 13 and CD10 in cases 1, 2,
and 3 .
restricted cell-surface antigens, but in addition, expressed intranuclear TdT
positivity (Table II) . In the absence ofTdT expression, all 13 cases would fit the
conventional diagnostic criteria ofFAB M1-M4 leukemias (24) . Coexpression of
the 3A1 (CD7) antigen and myeloid antigens was noted in 9 of the 13 AMLs .
CALLA (CD10) antigen was coexpressed with myeloid antigens in 3 of the 13
AML cases .
We studied the panel of 13 DNAs extracted from these leukemias by Southern
blot hybridization using T, 3andJH probes and theappropriate restriction enzymes
as described above . The complete analysis of eight representative cases is illus-
trated in Fig . 1, and data relative to analysis of the remaining cases are summa-
rized in Table 11 . In total, 8 of the 13 DNAs analyzed displayed detectable





















1 M 1 + +/ND +/+I - - - + R G
2 M I + +/ND +/+I - - - + R G
3 M 1 + +/ND -/+w - + - + G R
4 M I + +/- -/- - - - + R R
5 M 1 + +/- -/- - + - + G G
6 M2 + +/- -/- - + - + G R
7 M2 + +/+ -/- - + - + G R
8 M2 + +/- -/- - + - + G R
9 M2 + +/+ -/- - - - + G G
10 M2 + +/- -/- - + - + G G
11 M2 + +/- -/- - + - + G G
12 M2 + +/- -/- - + - + G G






M1 4 0 0
M2 8 0 1
M3 9 1 0
M4 2 0 0
M5 2 0 0SEREMETIS ET AL .
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FIGURE 1 . Ig and Ts rearrangements in TdT`
AML . Eco RI-digested DNA from normal human
fibroblasts (C) and from leukemic blasts (lanes 1-
4, 6, 7, 10, 13 correspond to DNA from cases so
numbered in Table II) were analyzed for gene
rearrangements using theJH probe (a) or the To
probe (b) .
rearrangements at the IgH locus, and 5 of the 13 displayed T,e rearrangements .
Case number three displayed rearrangements at both loci .
With respect to other lymphoid cell surface markers, we noted that all three
FAB-M1-TdT' leukemias expressing theCALLA(CD10) antigen also displayed
IgH or Ts gene rearrangements (IgH locus in two cases and T# locus in one case),
while five of the nine TdT+ AMLs expressing the CD7 antigen also displayed
rearrangements .
TdT+ Undifferentiated Leukemias Display Rearrangements at Both IgH and T, 3
Loci. Using the scheme of restriction enzyme digestion and probes described
above, we studied DNAs from four cases of undifferentiated acute leukemia that
were unclassifiable by conventional morphologic and cytoenzymatic criteria
(Table III) . Here cases were PAS- , MP-, andABE- . The B4(CD19) antigen was
detectable in case 1, and the MY9, CD13, and CD10 (CALLA) antigens were
detectable in case 3. The results of Southern blot hybridization are shown in Fig .
2 and summarized in Table III . Rearrangements at both the T# locus and the
IgH locus were clearly detected in all four cases .1708
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TABLE III






* R, rearranged ; G, germline .




Ig and To gene rearrangements in TdT+ undifferentiated acute leukemias . DNA
from normal human fibroblasts (C) and from tumor cells (lanes 1-4 correspond to DNA from
leukemias summarized in Table III) were analyzed for Ig and To gene rearrangement using
the indicated restriction enzymes and probes .
Discussion
The central observation of this study is the high frequency (>60%) of Ig
and/or Tp gene rearrangements in a subset ofAML selected solely on the basis
of their expression of the lymphoid marker TdT . Excepting TdT expression,
the phenotype of the blast cells from all of these patients unequivocally fulfilled
the morphological and cytochemical criteria ofAML by the FAB classification
and was in most respects analogous to TdT- AML, wherein Ig/T, 3 gene rear-
rangements were found at a consistently lower frequency (<8%) . These findings
have important implications for understanding : (a) the role of TdT in gene
rearrangements ; (b) the relationship between lymphoid and myeloid lineages ;
and (c) the use of phenotypic and genotypic markers in the classification of
leukemias .
Relationship between TdT Expression and Ig or Tp Gene Rearrangements .
￿
The
close association between TdT expression and Ig/T, 3 gene rearrangements de-
tectable in TdT+AML further suggests a role for TdT in the mechanism leading















1 Ut - - +/- - - - + R R
2 U - - -/- - - - + R R
3 U + + -/+ - - - + R R
4 U - - -/- - - - + R RSEREMETIS ET AL .
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catalyzes the non-template-directed addition of deoxynucleoside triphosphates
(31) . Based on this biochemical function and on its presence in lymphoid
precursors (32), it has been postulated that TdT may be responsible for the
insertion of extra, random nucleotides (N regions) at the site of V-DJ recombi-
nations during both Ig and To gene rearrangements (22, 23), therefore changing
thecoding potential of these genesand contributing to the generation ofantibody
and T cell receptor diversity (N diversity) (23) . The strong correlation between
TdT expression and the presence of Ig or T, 3 gene rearrangements in myeloid
cells provides further circumstantial evidence for this hypothesis by showing that
even outside the normal context of lymphoid differentiation, TdT expression
and Ig/Tg rearrangement act as coordinately controlled functions, most likely as
parts ofa functionally integrated program such as the assembly of Ig or Tß genes .
Implications for Lineage Commitment .
￿
One important concept emerging from
this study is that TdT expression in leukemic myeloblasts does not represent an
isolated and bizarre episode of lineage infidelity but is rather part ofa program
of differentiation that involves TdT, Ig or Tß gene rearrangement, and most
likely CD7 gene expression . A critical question here is whether the activation of
this program represents a pathologic phenomenon occurring in myeloid leuke-
mias or is part of the normal differentiative repertoire of myeloid cells . One
model that would be consistent with the former hypothesis is that leukemic
transformation involves the structural or functional alteration of a regulatory
gene that controls theactivation of the TdT/CD7/gene rearrangement program.
This hypothesis is difficult to test at present, because no evident and consistent
genetic alteration such as, for example, a specific chromosomal translocation has
been detected in TdT+ AML .
Alternatively, these leukemias may represent a clonal expansion of a normal
hematopoietic precursor the number ofwhich is relatively low in normal hema-
topoiesis and becomes detectable only in the case of leukemic transformation .
On this basis, at least two models for early differentiation events can be proposed .
First, TdT+ AMLs may reflect the existence of a stage in hematopoietic differ-
entiation wherein concomitant activity of many lineage-associated genes or
programs occur before commitment to a given lineage actually takes place . Thus,
the myeloid cytoenzymes and immunophenotype might reflect final lineage
commitments, whereas the gene rearrangement remains as an irreversible foot-
print of early precommitment lineage events . The TdT+ AMLs that do not
display Ig or T# gene rearrangements may represent cells that entered a myeloid
lineage commitment pathway after TdT and in some cases CD7 antigen expres-
sion, and before gene rearrangement . Second, these myeloid leukemias may
reflect the existence of a differentiative stage that marks lymphoid lineage
initiation or availability but not irreversible commitment . This stage could
include activation of a genetic program including TdT expression, gene rear-
rangement, and expression ofone or more early lymphoid lineage antigens (e.g .,
CD7 or CD10 antigens) ; however, the activation of this program would not
preclude a subsequent switch to the myeloid lineage.
Regardless of the exact pathway involved, the program involving previous
TdT expression and gene rearrangements is neither frequent nor necessary for
myeloid maturation, because most normal and leukemic myeloid cells are not171 0
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known to express TdT or display Ig/T# gene rearrangements. If, however, the
frequency of TdT+ AML (10%) reflects the approximate frequency of normal
myeloid elements carrying Ig or T, 3 gene rearrangements, the existence of these
elements could be proven directly by analyzing Ig or T# gene rearrangement in
mature myeloid elements.
Finally, the observation that all four undifferentiated leukemias we studied
displayed rearrangements at both the Ig and T, 3 loci is statistically provocative,
yet difficult to interpret. Ona purespeculative basis we could propose thatTdT+
undifferentiated leukemias may represent cases where leukemic transformation
has frozen the target cell in the differentiation "window" where rearrangements
actually occur, allowing for the accumulation of rearrangements of both Ig and
TCR due to the continuous activity ofa common recombinase (33).
Implications for Classification and Diagnosis of Leukemias and Lymphomas.
￿
It
has been proposed that Southern blot analysis and demonstration of Ig and To
gene rearrangements represents the definitive method for the identification of
clonal lymphoid populations. However, it is clear from the data presented here
that rearrangements are not strictly lineage specific and, furthermore, can be
consistently found in the context ofa well-characterized and relatively frequent
subgroup ofnonlymphoid malignancy. In agreement with previous reports (14-
16), the TdT+ AML patients studied here made a poor-prognosis subgroup, with
infrequent and nondurable remissions. Thus, the example ofTdT+ AML further
underscores the importance ofa combined immunophenotypic and immunogen-
otypic approach for the classification of all hematopoietic neoplasms (25). This
approach may lead not only to the discovery of novel differentiation pathways
but also to the identification ofnew clinicallyandprognostically relevant subtypes
of leukemias and lymphomas.
Summary
Ig and Tcell receptor rearrangements have been used as irreversible markers
of lineage and clonality in the study of B- and T-lymphoid populations. We have
addressed the issue of lymphoid lineage specificity of these rearrangements by
analyzing a panel of 25 TdT- acute myelogenous leukemias, 13 TdT+ AMLs,
and 4 TdT+ undifferentiated leukemias. We report that while gene rearrange-
ments represent extremely rare events in classical TdT- AML (<8%), rearrange-
ments ofeither the Ig or T, 3 locus or both were detectable in the majority ofthe
TdT+ AMLs (>60%), and rearrangements of both loci were detectable in all of
the TdT+ undifferentiated leukemias. These data demonstrate a significant
association between TdT expression and Ig or To gene rearrangements even
outside the lymphoid lineage, further supporting a role for TdT in Igand T cell
receptor gene assembly. These data also indicate that a coordinated program of
lymphoid gene expression involving TdT-CD7-expression and Ig/T, 3 rearrange-
ments can be activated before myeloid commitment. Whether the activation of
this program represents a normal, albeit rare, event in early myelopoiesis or a
transformation-related event present only in leukemic cells remains to be deter-
mined.
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